HistoSonics, Inc.

📍 Plymouth, United States🗓 Founded 2009👥 362 employees💰 Last funded Aug 2025
HistoSonics is a growth phase company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquefy and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels. The company’s new platform delivers personalized, tissue specific treatments with precision and control, and without the undesirable side effects of many of today’s interventional and surgical modalities. HistoSonics is led by a team of experienced domain experts and industry leaders with offices in Ann Arbor, MI, Madison, WI, and Minneapolis, MN.
6
Total investors
1
Early stage
0
Mid stage
1
Late stage
2009
Founded
Investor geography4 countries
United States
3
Canada
1
Hong Kong SAR
1
Singapore
1
Investor activity2009–2025 · investors recorded per year
200912019220253
Recent (last 2y)Earlier
Frequently asked questions
Who invested in HistoSonics, Inc.?
HistoSonics, Inc. has 6 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did HistoSonics, Inc. last raise funding?
The most recent investment in HistoSonics, Inc. recorded on gritt.io was in August 2025.
When was HistoSonics, Inc. founded?
HistoSonics, Inc. was founded in 2009.
What industry is HistoSonics, Inc. in?
HistoSonics, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is HistoSonics, Inc. based?
HistoSonics, Inc. is headquartered in Plymouth, United States.